To confirm and differentiate between human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections, we analyzed by polymerase chain reaction (PCR) samples of peripheral blood lymphocytes from 98 individuals seropositive for HTLV-I/II usingpol (SK110/111) and tax (SK43/44) consensus primer pairs. A total of 96 samples (97.9%) were positive by the tax generic probe, while 95 were typed by the HTLV-I and HTLV-II pol probes. The three pol-negative samples were successfully amplified and typed by nested PCR with primers internal to SK110 and SKill. Results of PCR with a lysate of leukocyte nuclei obtained by whole blood lysis were comparable to those obtained with peripheral blood lymphocytes from 16 HTLV-seropositive subjects.
The human T-cell lymphotropic virus type I (HTLV-I), endemic in Japan and the Caribbean, is also present in some parts of Africa and the Americas and is associated with adult T-cell leukemia/lymphoma and with HTLV-I-associated myelopathy, or tropical spastic paraperesis (5, 16) . HTLV-II is present among intravenous-drug users (3, 9, 14, 17) and has been found to be endemic among Native Americans in Panama and the United States (4, 5) . This virus has not yet been clearly associated with a disease.
Differentiation of the two infections is essential to studies of prevalence, demographic and behavioral risk factors, and possible disease associations and to counseling of infected persons. Polymerase chain reaction (PCR) has been instrumental in the differentiation of HTLV-I from HTLV-II (5, 9, 14, 15, 17) and remains indispensable both in characterizing samples that are untypeable by the newly developed typespecific serologic assays (13) and in studying seroindeterminate or seronegative subjects with risks for HTLV infection (7, 12) . It is also useful in mother-to-child transmission studies in which the serostatus of the newborn may not be a reliable indication of infection. Several groups have successfully used PCR to type HTLV infections in patients' peripheral blood lymphocytes (PBLs) using different primers and conditions (1, 3, 5, 6, 9, 14, 15, 17) . The sensitivities of such assays, however, have not been adequately determined with a large number of specimens from diverse geographical locations. We report PCR conditions that achieve 100% sensitivity and a simplified method for template preparation from whole blood.
Our study population was 98 HTLV-I/II seropositive individuals (2), including 32 blood donors from Atlanta, Ga after Southern blotting (18) . Measures to avoid PCR contamination as described previously were strictly followed (10) . All samples were initially subjected to two amplifications with tax SK43/44 and pol SK110/111 consensus primers, which allow the amplification of HTLV-I and HTLV-II. The product of the former reaction was hybridized to a generic tax probe (SK45), while that of the latter was hybridized to an HTLV-I-specific probe (SK112) and to another HTLV-II-specific probe (SK188) (11) . Of the 98 HTLV-I/II seropositive samples, 96 (97.9%) were positive by SK45. Of these, 95 samples (96.9%) were amplified by SK110/111 (27 hybridized to SK112, and 68 hybridized to SK188). We further confirmed this typing by subjecting a subset of 52 samples to two HTLV-I-specific amplifications (SK54/55 and GAG49/ 51) and two HTLV-II-specific amplifications (SK58/59 and 2G1/2G4) with type-specific probing ( Table 1) . The results correlated fully with those from SK110/111. All samples from the seronegative subjects were negative with all these primer pairs. The high sensitivities of SK43/44 and SK110/111 may be due in part to a lack of inter-or intraisolate sequence variation. Sequence analysis spanning the SK43/44 region of African, Japanese, and Caribbean HTLV-I isolates has not revealed any base changes (8) . The 100% specificity seen when the infection was typed by using SK112 and SK188 makes additional type-specific amplification reactions unnecessary.
To improve the sensitivity of our assay, we performed nested PCR on all three PCR-negative samples, using 20 ,ul of the initial SK110/111 amplification products as a template and POL1.1/3.1 and POL1.2/3.2, which lie inside SK110 and SK111 in HTLV-I and HTLV-II, respectively, as primers. Products of these amplifications were then probed with SK112 and POL2.2, respectively (Table 1) . Nested PCR successfully amplified and typed the three samples: two were positive for HTLV-II by POL2.2 and negative for HTLV-I, and one was positive for HTLV-I by SK112 and negative for HTLV-II (Fig. 1) . Doubling the input DNA of these samples or increasing the number of cycles to 45 did not result in positive amplifications. The ability of nested PCR to confirm HTLV-I or HTLV-II infection when routine J. CLIN. MICROBIOL. amplification failed to do so boosted the sensitivity to 100% and complemented the usefulness of the SK110/111 primers. A simple and rapid method for PCR template preparation that obviates the need for separation of mononuclear cells, which becomes labor-intensive in studies with large numbers of samples, is highly desirable. We have evaluated the usefulness of leukocyte nucleus preparations which are A made by mixing 1 to 3 ml of heparinized blood with 10 volumes of sterile cold (4°C) lysis buffer (0.32 M sucrose, 10 mM Tris-HCl [pH 7.5], 5 mM MgCl2, and 1% Triton X-100) and then centrifugating the mixture at 2,500 rpm (Beckman GDR centrifuge) for 10 min at 4°C. The pellet was washed once with sterile phosphate-buffered saline, suspended in 250 to 350 ,ul of PCR buffer, and then proteinase K digested. Equal volumes of PBL and nucleus lysates prepared from the same blood samples of 16 seropositive subjects were amplified with SK110/111. In all samples, signals obtained from the nucleus lysates were comparable to or stronger than those obtained from PBLs (Fig. 2) 
